Author: Arabian Media staff
The Strategic Defence Review has been billed as a 10-year stock take of UK defence and strategic priorities and will be eagerly read by contractors for hints at the government’s spending plans. This SDR, called by Prime Minister Sir Keir Starmer when he came to office last July, was undertaken in the shadow of the Ukraine war. Published on Monday, it emphasises a shift towards “warfighting readiness”, responding to heightened threats from “peer” adversaries such as Russia and China. What is in the SDR? While areas such as cyber conflict and the RAF receive investment, the Royal Navy stands out…
Curious about crypto investing but unsure where to start? You’re not alone. Interest in crypto is soaring due to its high potential return. For example, the value of one Bitcoin (BTC)—the first and most popular cryptocurrency—broke $100,000 for the first time in December 2024, while it was just above $50,000 earlier that year. However, cryptocurrencies are notoriously volatile and can drop in value just as fast. That’s why starting small is important, even if it’s just $100. “Your first $100 in crypto is about learning the space, not getting rich quick,” said Ryan Greiser, CFP, Opulus LLC co-founder, and Investopedia’s…
Your investment portfolio hit double digits last year, but somehow you’re not making any headway paying off thousands in credit card debt. Why? With average credit card interest rates soaring to 24.20% in May 2025 and continuing to climb, even the best investment strategies won’t pull you out of the financial quicksand. You have to “prioritize cash flow and stability—Do you have an emergency fund? Do you know your burn rate if income stops?” Stoy Hall, CEO and founder of Black Mammoth, told Investopedia. “If not, park the investment convo for now. But if you’re stable, this is when wealth is…
Nvidia is a significant investor in CoreWeave, and also sells the cloud company a lot of chips. Source link
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Biotechnology companies do two things, in an ideal world: make drugs that improve patient’s lives, and sell themselves — in whole or in part — to Big Pharma. This second element has been difficult to execute of late, because of high interest rates and uncertainty over the direction of US healthcare policy. Two chunky deals inked on Monday show that, when conditions are right, biotech investors can still win ample payouts. Sanofi, the French pharmaceuticals giant, said it had agreed to buy Blueprint…
DOGE attack on Social Security sparks anxiety about program’s stability Source link
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.If political rhetoric were a weapon, the UK would be close to impregnable. The verbal resolve of Prime Minister Sir Keir Starmer to put Britain in a state of “warfighting readiness” is admirable. Since the UK has Nato’s third highest defence budget after the US and Germany, his message should cheer allies. But there are big questions over the reality behind the rhetoric. It is not clear that Starmer’s Labour government is ready to move fast enough, on numbers and deployments, to…
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Google’s parent company Alphabet will spend at least $500mn over the next ten years on rebuilding its global compliance structure, under the terms of a proposed settlement with shareholders suing the company for alleged antitrust violations. The preliminary agreement follows a series of legal setbacks for the tech giant in the US. Multiple courts have found that the Silicon Valley group has monopolised the search, advertising and Android app markets, with the US government pushing for a potential break-up of the company.The settlement,…
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Chime Financial will seek to raise up to $832mn in an initial public offering this month, giving the US mobile banking group an $11.2bn valuation that is sharply reduced from four years ago. The San Francisco-based fintech, which is slated to list on the Nasdaq on June 12 under the ticker CHYM, will sell 32mn shares at a range of between $24 and $26 per share, according to a filing on Monday with the Securities and Exchange Commission. About 6mn of the…
When selecting investments, it is easy to get hung up on a particular metric, such as a dividend yield or a price ratio, but investors need to look deeper or they might miss opportunities. Source link